Target intelligence / Profile preview

Rab-interacting lysosomal protein-like 2 (RILPL2)

Target
RILPL2
Molecular classification
Other (Rab effector protein family; related but not identical to Rab-interacting lysosomal protein (RILP))
01

Overview

Rab-interacting lysosomal protein-like 2 (RILPL2) is a member of the RILP family of Rab effectors, closely related to Rab-interacting lysosomal protein (RILP) and RILP-like protein 1. RILPL2 is up-regulated during differentiation of multiciliated cells and localizes dynamically to the primary cilium and centrosome. It plays a crucial role in regulating the protein content of the ciliary membrane, possibly by promoting removal of proteins from the primary cilium. Unlike RILP, RILPL2 does not regulate lysosomal morphology or trafficking, but it binds activated forms of several Rab proteins (notably Rab34, Rab36, Rab12)[1][2][3]. Depletion of RILPL2 causes abnormal accumulation of signaling proteins in the ciliary membrane and disrupts epithelial cell organization in three-dimensional culture, implicating it in processes central to cilia function and potentially in ciliopathies[1]. Note: There is no evidence that RILPL2 is a therapeutic target (such as a well-validated receptor, enzyme, or transporter for drugs), nor are there known interacting drugs, mechanisms of action for drug targeting, biomarkers, or specific safety concerns reported in the available scientific literature[1][2][3].

Other names
RILP-like protein 2RLP2MGC7036FLJ30380FLJ32372rab-interacting lysosomal protein-like 2p40phox-binding protein
02

Biological functions

Regulation of ciliary membrane protein localization and compositionInteraction with Rab GTPases, such as Rab34, Rab36, and Rab12Regulation of membrane and cytoskeletal dynamics in dendritic spines
03

Disease associations

Other (potential contribution to ciliopathies through cilia dysfunction)

Beyond the preview

Go deeper on Rab-interacting lysosomal protein-like 2 (RILPL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rab-interacting lysosomal protein-like 2 (RILPL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call